{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:18:30Z","timestamp":1794395910836,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glansectomy with or without a neoglans reconstruction is commonly performed for invasive penile cancer confined to the glans penis. The aim of penile-preserving procedures is to maintain sexual and urinary function without compromising oncological outcomes. A systematic review was performed to evaluate the functional outcomes following glansectomy. Overall, 14 studies which included 327 glansectomy procedures were analysed. At a mean follow-up of 40.7 (range, 13\u201352) months, the recurrence rate was 9.1% (0\u201325%) and the disease-specific survival rate was 87.5\u2013100%. Partial graft loss and meatal stenosis occurred in 6.1% (0\u201317.6%) and 8.1% (0\u201314.3%) respectively. 91.1% (50\u2013100%) had preserved erectile function and 62.5% (33.3\u2013100%) were sexually active. 75.6% (66.7\u2013100%) of patients were voiding whilst standing up and 83.7% (63.6\u201391.2%) had maintained glans sensation. Satisfaction with the overall appearance was achieved in 86.3% (68.2\u2013100%). The reporting of functional outcomes was heterogenous with a limitation that there are no standardised guidelines on the assessment of functional outcomes following glansectomy. Further research should focus on identifying appropriate tools for reporting functional outcomes following glansectomy and standardising reporting.<\/jats:p>","DOI":"10.1038\/s41443-025-01062-1","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:16:56Z","timestamp":1744658216000},"page":"206-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional outcomes of glansectomy to treat localised penile cancer: a systematic review"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-2319","authenticated-orcid":false,"given":"Karl H.","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-0310","authenticated-orcid":false,"given":"Hussain M.","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2958-1614","authenticated-orcid":false,"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834","journal-title":"CA Cancer J Clin"},{"key":"1062_CR2","doi-asserted-by":"crossref","unstructured":"Brouwer OR, Rumble RB, Ayres B, S\u00e1nchez Mart\u00ednez DF, Oliveira P, Spiess PE, et al. Penile Cancer: EAU-ASCO collaborative guidelines update Q and A. JCO Oncol Pract. 2024;20:33\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/37956391\/","DOI":"10.1200\/OP.23.00585"},{"key":"1062_CR3","doi-asserted-by":"publisher","first-page":"103481","DOI":"10.1016\/J.ESMOOP.2024.103481","volume":"9","author":"A Muneer","year":"2024","unstructured":"Muneer A, Bandini M, Comp\u00e9rat E, De Meerleer G, Fizazi K, Gietema J, et al. Penile cancer: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024;9:103481 https:\/\/doi.org\/10.1016\/J.ESMOOP.2024.103481","journal-title":"ESMO Open"},{"key":"1062_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/J.EURURO.2016.09.048","volume":"73","author":"AS Parnham","year":"2018","unstructured":"Parnham AS, Albersen M, Sahdev V, Christodoulidou M, Nigam R, Malone P, et al. Glansectomy and split-thickness skin graft for penile cancer. Eur Urol. 2018;73:284\u20139. https:\/\/doi.org\/10.1016\/J.EURURO.2016.09.048","journal-title":"Eur Urol"},{"key":"1062_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/J.EUF.2021.11.008","volume":"8","author":"KH Pang","year":"2022","unstructured":"Pang KH, Muneer A, Alnajjar HM. Glansectomy and reconstruction for penile cancer: a systematic review. Eur Urol Focus. 2022;8:1318\u201322. https:\/\/doi.org\/10.1016\/J.EUF.2021.11.008","journal-title":"Eur Urol Focus"},{"key":"1062_CR6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71 https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1062_CR7","doi-asserted-by":"publisher","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, et al. Chapter 7: systematic reviews of etiology and risk. JBI Evid Synth. 2020. https:\/\/doi.org\/10.46658\/JBIMES-20-08.","DOI":"10.46658\/JBIMES-20-08"},{"key":"1062_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/S12874-024-02356-6","volume":"24","author":"A Abbas","year":"2024","unstructured":"Abbas A, Hefnawy MT, Negida A. Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis. BMC Med Res Methodol. 2024;24:243 https:\/\/doi.org\/10.1186\/S12874-024-02356-6","journal-title":"BMC Med Res Methodol"},{"key":"1062_CR9","doi-asserted-by":"publisher","unstructured":"Falcone M, Preto M, G\u00fcl M, \u015eahin A, Scavone M, Cirigliano L, et al. Functional outcomes of organ sparing surgery for penile cancer confined to glans and premalignant lesions. Int J Impot Res 2024. https:\/\/doi.org\/10.1038\/S41443-024-00967-7.","DOI":"10.1038\/S41443-024-00967-7"},{"key":"1062_CR10","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.3390\/CURRONCOL30120765","volume":"30","author":"S Cilio","year":"2023","unstructured":"Cilio S, Tufano A, Pezone G, Alvino P, Spena G, Pandolfo SD, et al. Sexual outcomes after conservative management for patients with localized penile cancer. Curr Oncol. 2023;30:10501\u20138. https:\/\/doi.org\/10.3390\/CURRONCOL30120765","journal-title":"Curr Oncol"},{"key":"1062_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/J.UROLOGY.2022.01.010","volume":"165","author":"M Falcone","year":"2022","unstructured":"Falcone M, Preto M, Blecher G, Timpano M, Peretti F, Ferro I, et al. The outcomes of glansectomy and split thickness skin graft reconstruction for invasive penile cancer confined to glans. Urology. 2022;165:250\u20135. https:\/\/doi.org\/10.1016\/J.UROLOGY.2022.01.010","journal-title":"Urology"},{"key":"1062_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.urology.2021.02.011","volume":"152","author":"SM Croghan","year":"2021","unstructured":"Croghan SM, Compton N, Daniels AE, Fitzgibbon L, Daly PJ, Cullen IM. Phallus preservation in penile cancer surgery: patient-reported aesthetic & functional outcomes. Urology. 2021;152:60\u20136. https:\/\/doi.org\/10.1016\/j.urology.2021.02.011","journal-title":"Urology"},{"key":"1062_CR13","first-page":"E482","volume":"14","author":"B Beech","year":"2020","unstructured":"Beech B, Chapman D, Rourke K. Clinical outcomes of glansectomy with split-thickness skin graft reconstruction for localized penile cancer. Can Urol Assoc J. 2020;14:E482\u201386.","journal-title":"Can Urol Assoc J"},{"key":"1062_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2020.03.058","volume":"142","author":"J P\u00e9rez","year":"2020","unstructured":"P\u00e9rez J, Chavarriaga J, Ortiz A, Orrego P, Rueda S, Quiroga W, et al. Oncological and functional outcomes after organ-sparing plastic reconstructive surgery for penile cancer. Urology. 2020;142:161\u20135.e1. https:\/\/doi.org\/10.1016\/j.urology.2020.03.058","journal-title":"Urology"},{"key":"1062_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/21681805.2014.955822","volume":"49","author":"U H\u00e5kansson","year":"2015","unstructured":"H\u00e5kansson U, Kirrander P, Uvelius B, Baseckas G, Torbrand C. Organ-sparing reconstructive surgery in penile cancer: initial experiences at two Swedish referral centres. Scand J Urol. 2015;49:149\u201354. https:\/\/doi.org\/10.3109\/21681805.2014.955822","journal-title":"Scand J Urol"},{"key":"1062_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/sm2.56","volume":"3","author":"K Scarberry","year":"2015","unstructured":"Scarberry K, Angermeier KW, Montague D, Campbell S, Wood HM. Outcomes for organ-preserving surgery for penile cancer. Sex Med. 2015;3:62\u20136. https:\/\/doi.org\/10.1002\/sm2.56","journal-title":"Sex Med"},{"key":"1062_CR17","doi-asserted-by":"publisher","first-page":"E423","DOI":"10.5489\/cuaj.2801","volume":"9","author":"O Sedigh","year":"2015","unstructured":"Sedigh O, Falcone M, Ceruti C, Timpano M, Preto M, Oderda M, et al. Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results? Can Urol Assoc J. 2015;9:E423\u20137. https:\/\/doi.org\/10.5489\/cuaj.2801","journal-title":"Can Urol Assoc J"},{"key":"1062_CR18","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/j.1464-410X.2012.11084.x","volume":"110","author":"R Veeratterapillay","year":"2012","unstructured":"Veeratterapillay R, Sahadevan K, Aluru P, Asterling S, Rao GS, Greene D. Organ-preserving surgery for penile cancer: description of techniques and surgical outcomes. BJU Int. 2012;110:1792\u20135. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11084.x","journal-title":"BJU Int"},{"key":"1062_CR19","doi-asserted-by":"publisher","unstructured":"O\u2019Kane HF, Pahuja A, Ho KJ, Thwaini A, Nambirajan T, Keane P Outcome of glansectomy and skin grafting in the management of penile cancer. Adv Urol 2011;2011:240824. https:\/\/doi.org\/10.1155\/2011\/240824.","DOI":"10.1155\/2011\/240824"},{"key":"1062_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.aju.2011.06.013","volume":"9","author":"E Palminteri","year":"2011","unstructured":"Palminteri E, Fusco F, Berdondini E, Salonia A. Aesthetic neo-glans reconstruction after penis-sparing surgery for benign, premalignant or malignant penile lesions. Arab J Urol. 2011;9:115\u201320. https:\/\/doi.org\/10.1016\/j.aju.2011.06.013","journal-title":"Arab J Urol"},{"key":"1062_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ijir.2009.17","volume":"21","author":"G Morelli","year":"2009","unstructured":"Morelli G, Pagni R, Mariani C, Campo G, Menchini-Fabris F, Minervini R, et al. Glansectomy with split-thickness skin graft for the treatment of penile carcinoma. Int J Impot Res. 2009;21:311\u20134. https:\/\/doi.org\/10.1038\/ijir.2009.17","journal-title":"Int J Impot Res"},{"key":"1062_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.juro.2007.05.059","volume":"178","author":"G Gulino","year":"2007","unstructured":"Gulino G, Sasso F, Falabella R, Bassi PF. Distal urethral reconstruction of the glans for penile carcinoma: results of a novel technique at 1-year of followup. J Urol. 2007;178:941\u20134. https:\/\/doi.org\/10.1016\/j.juro.2007.05.059","journal-title":"J Urol"},{"key":"1062_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822\u201330. https:\/\/doi.org\/10.1016\/S0090-4295(97)00238-0","journal-title":"Urology"},{"key":"1062_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/00926230500232909","volume":"32","author":"A Keller","year":"2006","unstructured":"Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the changes in sexual functioning questionnaire short-form (CSFQ-14). J Sex Marital Ther. 2006;32:43\u201352. https:\/\/doi.org\/10.1080\/00926230500232909","journal-title":"J Sex Marital Ther"},{"key":"1062_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","volume":"50","author":"M Groenvold","year":"1997","unstructured":"Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50:441\u201350. https:\/\/doi.org\/10.1016\/S0895-4356(96)00428-3","journal-title":"J Clin Epidemiol"},{"key":"1062_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/S10198-018-0955-5","volume":"20","author":"MF Janssen","year":"2019","unstructured":"Janssen MF, Szende A, Cabases J, Ramos-Go\u00f1i JM, Vilagut G, K\u00f6nig HH. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20:205\u201316. https:\/\/doi.org\/10.1007\/S10198-018-0955-5","journal-title":"Eur J Health Econ"},{"key":"1062_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/NAU.20041","volume":"23","author":"K Avery","year":"2004","unstructured":"Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23:322\u201330. https:\/\/doi.org\/10.1002\/NAU.20041","journal-title":"Neurourol Urodyn"},{"key":"1062_CR28","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0022-5347(05)66926-1","volume":"164","author":"JL Donovan","year":"2000","unstructured":"Donovan JL, Peters TJ, Abrams P, Brookes ST, de aa Rosette JJ, Sch\u00e4fer W. Scoring the short form ICSmaleSF questionnaire. International continence society. J Urol. 2000;164:1948\u201355.","journal-title":"J Urol"},{"key":"1062_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/J.1743-6109.2009.01643.X","volume":"7","author":"JW Shaw","year":"2010","unstructured":"Shaw JW, Reardon G, Sandor DW, Rosen RC, Ferguson DM. Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile function in patients treated with a phosphodiesterase type 5 inhibitor. J Sex Med. 2010;7:1147\u201359. https:\/\/doi.org\/10.1111\/J.1743-6109.2009.01643.X","journal-title":"J Sex Med"},{"key":"1062_CR30","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol. 1992;148:1549\u201357. https:\/\/doi.org\/10.1016\/S0022-5347(17)36966-5","journal-title":"J Urol"},{"key":"1062_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00752814","volume":"27","author":"DA Bigelow","year":"1991","unstructured":"Bigelow DA, Young DJ. Effectiveness of a case management program. Community Ment Health J. 1991;27:115\u201323. https:\/\/doi.org\/10.1007\/BF00752814","journal-title":"Community Ment Health J"},{"key":"1062_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/J.EUF.2021.09.019","volume":"7","author":"JK Jakobsen","year":"2021","unstructured":"Jakobsen JK, Pettaway CA, Ayres B. Centralization and equitable care in rare urogenital malignancies: the case for penile cancer. Eur Urol Focus. 2021;7:924\u20138. https:\/\/doi.org\/10.1016\/J.EUF.2021.09.019","journal-title":"Eur Urol Focus"},{"key":"1062_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1464-410X.2010.09576.x","volume":"107","author":"PR Malone","year":"2011","unstructured":"Malone PR, Thomas JS, Blick C. A tie-over dressing for graft application in distal penectomy and glans resurfacing: The TODGA technique. BJU Int. 2011;107:836\u201340. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09576.x","journal-title":"BJU Int"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01062-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:58:30Z","timestamp":1773835110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01062-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01062-1","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Photos are taken from the senior authors\u2019 institutional (UCLH) collection and informed consent was obtained from patients for collection and publication. The review was conducted with reference to the 2020 PRISMA statement. No ethical approval to conduct a review was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}